Stockreport

Omeros Announces Robust Results for Narsoplimab Expanded Access Program in TA-TMA [Yahoo! Finance]

Omeros Corporation  (OMER) 
Last omeros corporation earnings: 3/2 04:03 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.omeros.com
PDF Results of statistical analyses of survival in narsoplimab-treated expanded access program (EAP) TA-TMA patients compared to similarly at-risk external control registry [Read more]